Somatostatin receptor expression in multiple endocrine neoplasia and in von Hippel-Lindau disease

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 569-571

  Lamberts, S W J ^a,b   Hofland, L J ^a   Lely, A J V D ^a   De Herder, W W ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Multiple endocrine neoplasia; Somatostatin receptors; Von Hippel Lindau disease

Indexed keywords

RADIOISOTOPE; SOMATOSTATIN RECEPTOR;

CONFERENCE PAPER; ELECTROLYTE DISTURBANCE; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; RECEPTOR BINDING; VON HIPPEL LINDAU DISEASE;

GENE EXPRESSION REGULATION, NEOPLASTIC; HIPPEL-LINDAU DISEASE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; RECEPTORS, SOMATOSTATIN;

EID: 0031808131     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00340.x     Document Type: Conference Paper

References (21)

1. Lamberts SWJ, van der LeLy AJ, de Herder WW, Hofland LJ. Octreotide. New Engl J Med 1996; 334: 246-54.
2. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogues in the diagnosis and treatment of tumours. Endocrine Rev 1991; 12: 450-82.
3. Reubi JC, Landolt AM. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J Clin Endocrinol Metab 1989; 68: 844-50.
4. Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KJ, del Pozo E. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 1985; 313: 1576-80.
5. Lamberts SWJ. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogues in the treatment of human pituitary tumours. Endocrine Rev 1988; 9: 417-36.
6. Kvols LK, Buck M, Moertel CG et al. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann intern Med 1987; 107: 162-8.
7. Kvols LK, Moertel CG, O'Connell MJ. Treatment of the malignant carcinoid syndrome, evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 5663-6.
8. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993; 20: 283-92.
9. Kwekkeboom DJ, Reubi JC, Lamberts SWJ et al. In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 1993; 76: 1413-7.
10. Reubi JC, Waser B, Lamberts SWJ, Mengod G. Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumours using in situ hybridization histochemistry: comparison with SRIH receptor content. J Clin Endocrinol Metab 1993; 76: 642-7.
11. Reubi JC, Waser B, Laissue JA, Gebbers JO. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumours: in vitro identification. Cancer Res 1992; 56: 1922-31.
12. Reubi JC, Kvols L. Somatostatin receptors in human renal cell carcinomas. Cancer Res 1992; 52: 6074-8.
13. Krenning EP, Bakker WH, Breeman WAP et al. Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1989; I: 242-4.
14. Krenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with [IIIIn DTPA D Phe1] and [123I Tyr3] octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-31.
15. Lamberts SWJ, Hofland LJ, van Koetsveld PM et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumours. Consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 1990; 71: 566-74.
16. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumours. N Engl J Med 1990; 323: 1246-9.
17. Termanini B, Gibril F, Reynolds JC et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterol 1997; 112: 335-47.
18. Krenning EP, Kooij PPM, Bakker WH et al. Radiotherapy with a radiolabeled somatostatin analogue [IIIIn DTPA D PheI] octreotide. A case history. Ann NY Acad Sci 1994; 733: 496-506.
19. Schirmer WJ, O'Dorisio TM, Schirmer TP, Mojzisik CM, Hinkle GH, Martin EW. Intraoperative localization of neuroendocrine tumours with 1251 Tyr (3) octreotide and a hand held gamma detecting probe. Surgery 1993; 114: 745-52.
20. Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WAP, Lamberts SWJ. Internalization of the radioiodinated somatostatin analogue [125I-Tyr3] octreotide by mouse and human pituitary tumour cells: increase by unlabeled octreotide. Endocrinology 1995; 136: 3698-706.
21. Radulovic S, Nagy A, Stroke B, Schally AV. Cytotoxic analogue of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Cancer Lett 1992; 62: 263-71.